Science & Enterprise subscription

Follow us on Twitter

  • FDA today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor n… https://t.co/C8uIamFD3C
    about 13 hours ago
  • New post on Science and Enterprise: FDA Approves Rare Infant Disease Gene Therapy https://t.co/wqx9iCTxVe #Science #Business
    about 13 hours ago
  • FDA Approves First Mesothelioma Treatment in 15 Years https://t.co/PnKrL24HW0 via @medscape ATTN: @innerarchitect @deansguide
    about 17 hours ago
  • A neuroscience lab in the U.K. designed a process using virtual reality to detect early-stage Alzheimer's disease i… https://t.co/SrIZhdhyLJ
    about 17 hours ago
  • New post on Science and Enterprise: Virtual Reality Harnessed to Detect Alzheimer’s https://t.co/tJrT1Q6LsE #Science #Business
    about 17 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Viral Disease Biotech Joins ElevateBio, Gains $120M

T-cells illustration

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M

Start-Up to Use Stem Cells for Hearing Loss

Headphones

A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss

Company Helps Labs Build Gene, Cell Therapy Businesses

DNAmolcule model

A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses

Infographic – Machine Learning Grabs Most A.I. Investments

A.I. investment chart

So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic. . . . → Read More: Infographic – Machine Learning Grabs Most A.I. Investments

Companies Partner on Kidney Disease in $2B Deal

Goldfinch

A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal

Start-Up to Use Crispr for Heart Disease, Gains $59M

Editing DNA

A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M

Synthetic Soft Tissue Developed for Surgery

Surgery

Researchers developed a synthetic soft tissue for plastic and reconstructive surgery that in animal tests looks and performs more like real tissue. . . . → Read More: Synthetic Soft Tissue Developed for Surgery

Infographic – Venture Deals Cool Off in Q1 2019

Chart, venture funding by quarter

Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018. . . . → Read More: Infographic – Venture Deals Cool Off in Q1 2019

Biotechs Partner on Gene Silencing in $1.1B Deal

Retinal gene therapy

Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal

Radiation-Antibody Biotech Raises $105M in Venture Funds

John Valiant

A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing. . . . → Read More: Radiation-Antibody Biotech Raises $105M in Venture Funds